Arrowgrass Capital Partners (US)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-91,209
Closed -$1.79M 202
2014
Q1
$1.79M Buy
91,209
+16,209
+22% +$319K 0.07% 122
2013
Q4
$1.26M Buy
+75,000
New +$1.26M 0.06% 108